Catalyst Wire Dossier Catalyst Wire Dossier

Bortezomib

bortezomib · Camber Pharmaceuticals, Inc.
Drug timelines are a Plus or Pro feature.

365 regulatory and trial events tracked for Bortezomib, covering 2006-12-04 to 2026-08-10. Get the full timeline:

Most recent: Clinical Trial Results: A Study of Evaluating the Safety and Efficacy of ATG-010, Bortezomib, and Dexamethasone (SVd) Versus Bortezomib and Dexamethasone (Vd) in Patients With Relapsed or Refractory Multiple Myeloma (RRMM) [Phase 3]

See pricing